Evaluation of Mild Cognitive Impairment through Perientorhinal/Hippocampal Imaging and Comprehensive

Sara Invitto1, Paolo Boscolo-Rizzo2, Giacomo Spinato3

  • 1Laboratory on Cognitive and Psychophysiological Olfactory Processes, Department of Biological and Environmental Science and Technologies, University of Salento, 73100 Lecce, Italy.

Brain Sciences
|July 27, 2024
PubMed

Insights

Anxiety may worsen mild cognitive impairment (MCI) progression, as indicated by entorhinal cortical atrophy (ERICA) scores. Early detection of MCI and anxiety is crucial for potential interventions.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) is a precursor to dementia, necessitating early detection for intervention.
  • Olfactory impairment serves as an early biomarker for neurodegenerative diseases.
  • Assessing brain structure and cognitive function is vital for understanding MCI progression.

Purpose of the Study:

  • To investigate the relationship between entorhinal cortical atrophy (ERICA) and MCI symptom severity.
  • To analyze MRI findings in specific brain regions (entorhinal cortex, parahippocampal gyrus, etc.).
  • To conduct comprehensive neuropsychological and psychophysical assessments in MCI patients.

Main Methods:

  • Utilized magnetic resonance imaging (MRI) to measure entorhinal cortical atrophy (ERICA).
  • Performed detailed neuropsychological assessments to evaluate cognitive function.
  • Included psychophysical evaluations, focusing on olfactory function and anxiety symptoms.

Main Results:

  • Found a significant association between ERICA scores and anxiety symptom severity in multidomain amnestic MCI patients with hyposmia.
  • Hypothesized that chronic stress and inflammation from anxiety may contribute to neurodegeneration.
  • Highlighted the link between psychological factors and MCI progression.

Conclusions:

  • Psychological factors, particularly anxiety, play a role in the progression of mild cognitive impairment.
  • Neuroimaging and neuropsychological assessments are valuable tools for early MCI detection and patient monitoring.
  • Further longitudinal research is needed to confirm the predictive value of anxiety and brain atrophy in MCI.